PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 58 filers reported holding PARDES BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,800,944 | +20.1% | 994,997 | -12.4% | 0.00% | – |
Q1 2023 | $1,498,924 | -21.5% | 1,135,549 | +0.5% | 0.00% | – |
Q4 2022 | $1,910,023 | -8.1% | 1,130,191 | +0.6% | 0.00% | – |
Q3 2022 | $2,079,000 | -38.5% | 1,123,858 | +2.0% | 0.00% | – |
Q2 2022 | $3,383,000 | -52.5% | 1,102,034 | +11.8% | 0.00% | – |
Q1 2022 | $7,118,000 | – | 985,974 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Opportunity Management V, LLC | 5,227,307 | $9,671,000 | 29.04% |
Foresite Capital Management V, LLC | 9,400,515 | $17,391,000 | 13.37% |
Lynx1 Capital Management LP | 2,275,732 | $4,210,000 | 3.80% |
VK Services, LLC | 6,151,766 | $11,381,000 | 1.70% |
Arena Capital Advisors, LLC- CA | 851,281 | $1,575,000 | 0.48% |
RA Capital Management | 6,175,038 | $11,424,000 | 0.24% |
DAFNA Capital Management LLC | 479,386 | $887,000 | 0.24% |
Chescapmanager LLC | 361,716 | $669,000 | 0.16% |
Altai Capital Management | 82,097 | $152,000 | 0.15% |
Frazier Life Sciences Management, L.P. | 845,636 | $1,564,000 | 0.12% |